Financials

  • Market Capitalization 271.99 M
  • Employee 35
  • Founded 2008
  • CEO N/A
  • Website www.inhibikase.com
  • Headquarter Delaware, United States
  • FIGI BBG005TP2339
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.18
市销率
53.93

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3389
MGNX
MacroGenics, Inc. - Common Stock
4.30 USD-4.44%-9.47%+8.59%+173.89%273.32 M USD
3398
SABS
SAB Biotherapeutics, Inc. - Common Stock
3.60 USD-3.49%-7.69%+4.65%+48.76%275.27 M USD
3410
GLSI
Greenwich LifeSciences, Inc. - Common stock
19.03 USD+2.48%+2.48%-22.07%+78.02%279.33 M USD
3433
SRZN
Surrozen, Inc. - Common Stock
21.89 USD-4.03%-4.87%-8.72%+157.23%254.15 M USD

新闻